Pembrolizumab/nintedanibVarious toxicities: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1777卷 / 1期

关键词：

D O I：

10.1007/s40278-019-70779-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：196 / 196

相关论文

共 50 条

[31] Pembrolizumab/methylprednisolone/mycophenolateVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2021, 1876 (1) : 277 - 277
[32] Cobimetinib/pembrolizumab/trametinibVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2023, 1960 (1) : 149 - 149
[33] Budesonide/pembrolizumab/proton-pump-inhibitorsVarious toxicities: case report
Reactions Weekly, 2025, 2045 (1) : 88 - 88
[34] Dexamethasone/pembrolizumab/prednisoneGiant cell arteritis and other toxicities: case report
Reactions Weekly, 2022, 1887 (1) : 267 - 267
[35] Pembrolizumab/carboplatin/etoposideVarious toxicities and off-label-use: case report
Reactions Weekly, 2023, 1938 (1) : 1065 - 1065
[36] Pembrolizumab/prednisoneVarious toxicities: 2 case reports
Reactions Weekly, 2021, 1865 (1) : 357 - 357
[37] Methylprednisolone/pembrolizumab/pyridostigmineVarious toxicities following drug toxicity and lack of efficacy: case report
Reactions Weekly, 2023, 1943 (1) : 429 - 429
[38] Axitinib/pembrolizumab/thiamazoleVarious toxicities: 2 case reports
Reactions Weekly, 2023, 1941 (1) : 85 - 85
[39] Camrelizumab/pembrolizumab/toripalimabVarious toxicities : 4 case reports
Reactions Weekly, 2024, 2021 (1) : 128 - 128
[40] Paclitaxel/pembrolizumab/temozolomideVarious toxicities: 3 case reports
Reactions Weekly, 2020, 1811 (1) : 223 - 223

← 1 2 3 4 5 →